Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Mar-24 5:59 PM View:  | Denali Therapeutics Inc. (DNLI) | 29-Mar-24 | Gift | 40,000 | -- | -- | (2%) 2.48M to 2.44M | |
| 15-Feb-24 9:15 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 9,589 | $17.29 | $165,794.00 | (< 1%) 2.49M to 2.48M | |
| 11-Jan-24 5:28 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Jan-24 | Sale | 7,818 | $19.78 | $154,640.00 | (< 1%) 2.5M to 2.49M | |
| 09-Jan-24 7:33 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale | 17,483 | $19.43 | $339,695.00 | (< 1%) 2.52M to 2.5M | |
| 05-Jan-24 5:56 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-24 | Grant | 89,520 | -- | -- | 4% 2.43M to 2.52M | |
| 23-Aug-23 4:32 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 2,309 | $22.59 | $52,160.30 | (< 1%) 2.43M to 2.43M | |
| 14-Aug-23 5:13 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Aug-23 | Option Exercise | 2,526 | $0.68 | $1,717.68 | < 1% 2.43M to 2.43M | |
| 14-Aug-23 5:13 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Aug-23 | Planned Option Sale | 2,526 | $25.03 | $63,225.80 | (< 1%) 2.43M to 2.43M | |
| 24-Apr-23 7:10 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Apr-23 | Option Exercise | 24,800 | $0.68 | $16,864.00 | 1% 2.43M to 2.45M | |
| 24-Apr-23 7:10 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Apr-23 | Planned Option Sale | 24,800 | $25.15 | $623,720.00 | (1%) 2.45M to 2.43M | |
| 24-Apr-23 7:10 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Apr-23 | Option Exercise | 200 | $0.68 | $136.00 | < 1% 2.43M to 2.43M | |
| 24-Apr-23 7:10 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Apr-23 | Planned Option Sale | 200 | $25.00 | $5,000.00 | (< 1%) 2.43M to 2.43M | |
| 15-Feb-23 7:01 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Option Exercise | 25,000 | $0.68 | $17,000.00 | 1% 2.44M to 2.46M | |
| 15-Feb-23 7:01 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Option Sale | 8,815 | $30.09 | $265,243.00 | (< 1%) 2.46M to 2.45M | |
| 15-Feb-23 7:01 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Planned Option Sale | 16,185 | $30.08 | $486,845.00 | (< 1%) 2.45M to 2.44M | |
| 15-Feb-23 7:01 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Sale (Planned) | 8,815 | $30.08 | $265,155.00 | (< 1%) 2.44M to 2.43M | |
| 13-Feb-23 7:14 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Feb-23 | Option Exercise | 25,000 | $0.68 | $17,000.00 | 1% 2.44M to 2.46M | |
| 13-Feb-23 7:14 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Feb-23 | Planned Option Sale | 21,567 | $29.10 | $627,600.00 | (< 1%) 2.46M to 2.44M | |
| 13-Feb-23 7:14 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Feb-23 | Sale (Planned) | 3,433 | $29.10 | $99,900.30 | (< 1%) 2.44M to 2.44M | |
| 13-Feb-23 7:14 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-23 | Option Sale | 3,433 | $30.59 | $105,015.00 | (< 1%) 2.44M to 2.44M | |
| 09-Jan-23 9:41 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-23 | Sale | 4,800 | $28.44 | $136,512.00 | (< 1%) 2.45M to 2.44M | |
| 05-Jan-23 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Jan-23 | Sale | 5,029 | $28.73 | $144,483.00 | (< 1%) 2.45M to 2.45M | |
| 05-Jan-23 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-23 | Grant | 82,240 | -- | -- | 3% 2.37M to 2.45M | |
| 23-Aug-22 4:48 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-22 | Sale | 2,404 | $33.22 | $79,860.90 | (< 1%) 2.37M to 2.37M | |
| 15-Feb-22 6:58 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-22 | Sale | 9,491 | $34.72 | $329,528.00 | (< 1%) 2.38M to 2.37M | |
| 11-Feb-22 5:19 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Feb-22 | Option Exercise | 70,749 | $5.65 | $399,984.00 | 3% 2.31M to 2.38M | |
| 11-Feb-22 5:19 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-22 | Market Option Sale | 2,719 | $37.55 | $102,104.00 | (< 1%) 2.31M to 2.31M | (8%) |
| 07-Jan-22 6:06 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-22 | Market Sale | 5,007 | $44.78 | $224,213.00 | (< 1%) 2.32M to 2.31M | 2% |
| 05-Jan-22 7:03 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-22 | Grant | 62,000 | -- | -- | 3% 2.26M to 2.32M | |
| 03-Dec-21 4:23 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Dec-21 | Market Sale (Planned) | 18,333 | $44.92 | $823,581.00 | (< 1%) 2.27M to 2.26M | < 1% |
| 03-Nov-21 5:32 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Nov-21 | Market Sale (Planned) | 18,333 | $49.76 | $912,176.00 | (< 1%) 2.29M to 2.27M | (3%) |
| 05-Oct-21 4:27 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Oct-21 | Market Sale (Planned) | 18,333 | $50.38 | $923,550.00 | (< 1%) 2.31M to 2.29M | (< 1%) |
| 03-Sep-21 6:53 AM View: | Denali Therapeutics Inc. (DNLI) | 01-Sep-21 | Market Sale (Planned) | 18,333 | $54.66 | $1,002,010.00 | (< 1%) 2.33M to 2.31M | (2%) |
| 23-Aug-21 8:25 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-21 | Market Sale | 2,376 | $49.57 | $117,769.00 | (< 1%) 2.33M to 2.33M | 1% |
| 04-Aug-21 7:14 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Aug-21 | Market Sale (Planned) | 18,333 | $51.41 | $942,477.00 | (< 1%) 2.35M to 2.33M | < 1% |
| 06-Jul-21 4:14 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Jul-21 | Market Sale (Planned) | 18,333 | $77.25 | $1,416,300.00 | (< 1%) 2.37M to 2.35M | < 1% |
| 03-Jun-21 8:08 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Jun-21 | Market Sale (Planned) | 18,333 | $61.40 | $1,125,650.00 | (< 1%) 2.39M to 2.37M | (4%) |
| 05-May-21 4:13 PM View: | Denali Therapeutics Inc. (DNLI) | 03-May-21 | Market Sale (Planned) | 18,333 | $58.64 | $1,075,100.00 | (< 1%) 2.4M to 2.39M | 5% |
| 05-Apr-21 4:09 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Apr-21 | Market Sale (Planned) | 18,334 | $56.60 | $1,037,680.00 | (< 1%) 2.42M to 2.4M | |
| 05-Apr-21 4:09 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Mar-21 | Gift | 40,000 | -- | -- | (2%) 2.46M to 2.42M | |
| 03-Mar-21 4:19 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Mar-21 | Market Sale (Planned) | 18,334 | $66.35 | $1,216,550.00 | (< 1%) 2.48M to 2.46M | 5% |
| 16-Feb-21 7:40 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-21 | Market Sale | 9,473 | $70.30 | $665,984.00 | (< 1%) 2.49M to 2.48M | 4% |
| 10-Feb-21 7:40 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-21 | Market Option Sale | 5,112 | $73.79 | $377,211.00 | (< 1%) 2.32M to 2.31M | |
| 10-Feb-21 7:40 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Feb-21 | Option Exercise | 14,316 | -- | -- | < 1% 2.3M to 2.32M | |
| 02-Feb-21 9:21 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Feb-21 | Market Sale (Planned) | 18,334 | $68.44 | $1,254,820.00 | (< 1%) 2.32M to 2.3M | (2%) |
| 06-Jan-21 6:49 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Jan-21 | Market Sale (Planned) | 88,334 | $74.96 | $6,621,780.00 | (4%) 2.41M to 2.32M | 6% |
| 18-Jun-20 9:42 PM View: | Denali Therapeutics Inc. (DNLI) | 18-Jun-20 | Gift | 40,000 | -- | -- | (2%) 2.45M to 2.41M | |
| 01-Apr-20 6:17 PM View: | Denali Therapeutics Inc. (DNLI) | 30-Mar-20 | Market Sale | 4,807 | $19.48 | $93,640.40 | (< 1%) 2.46M to 2.45M | 2% |
| 05-Dec-19 4:29 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Dec-19 | Market Sale (Planned) | 18,755 | $18.00 | $337,590.00 | (< 1%) 2.46M to 2.44M | (6%) |
| 05-Dec-19 4:29 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Dec-19 | Market Sale (Planned) | 2,513 | $18.02 | $45,284.30 | (< 1%) 2.46M to 2.46M | (6%) |